Bakuchi
Psoralea corylifolia L. (syn. Cullen corylifolium)
Bakuchi (Psoralea corylifolia L. (syn. Cullen corylifolium)) is a plant used in Ayurveda. Psoralea corylifolia is listed in the WHO monograph on selected medicinal plants (Volume 4).
| Botanical name | Psoralea corylifolia L. (syn. Cullen corylifolium) |
|---|---|
| Currently accepted name | Cullen corylifolium (L.) Medik. — the name above is treated as a synonym by GBIF; both are in use |
| Family | Fabaceae · other entries in this family |
| Order | Fabales |
| Pharmacopoeia status | Psoralea corylifolia is listed in the WHO monograph on selected medicinal plants (Volume 4). Psoralen and isopsoralen are recognized pharmacopeial compounds. WHO acknowledges traditional use for vitiligo and psoriasis but recommends medical supervision due to photosensitivity risks. |
| Taxon identifiers | GBIF 2948931 · Wikidata Q3595165 · NCBI Taxonomy 429560 |
Names and identification
| Language | Name |
|---|---|
| English | Bakuchi |
| Latin/Botanical | Psoralea corylifolia L. (syn. Cullen corylifolium) |
Key Phytochemical Constituents
- Psoralen (furanocoumarin - primary photosensitizing agent)
- Bakuchiol (meroterpene phenol - retinol-like anti-aging compound)
- Isopsoralen (angelicin)
- Psoralidin (prenylated flavonoid)
- Bavachinin (flavanone)
- Bakuchalcone (chalcone)
- Corylifolin
- Bergapten (5-methoxypsoralen)
How does it work?
- Psoralen-mediated PUVA photochemotherapy: Psoralen intercalates with DNA in melanocytes, and upon UVA exposure, forms crosslinks that stimulate melanogenesis for vitiligo repigmentation
- Bakuchiol retinoid-like signaling: Activates retinoid signaling pathways (stimulates type I, III, and IV collagen synthesis and inhibits MMP-1 expression) without binding retinoid receptors directly
- Tyrosinase activation pathway: Furanocoumarins stimulate tyrosinase enzyme activity in melanocytes, increasing melanin biosynthesis through enhanced DOPA oxidation
- Anti-inflammatory NF-kB suppression: Psoralidin and bavachinin inhibit NF-kB activation and downstream inflammatory cytokine production (TNF-alpha, IL-6), reducing psoriatic inflammation
Which traditional uses are supported by research?
- Vitiligo (Shvitra/Kilasa) treatment: Validated through multiple clinical case studies and PUVA therapy protocols using psoralen as the gold-standard photosensitizer
- Psoriasis (Ekakushtha) management: Psoralen-UVA combination therapy is an established dermatological treatment, directly derived from traditional Bakuchi use
- Anti-aging and photoprotection: Bakuchiol validated in double-blind RCTs as comparable to retinol for wrinkle reduction, pigmentation, and skin firmness improvement
- Wound healing: Traditional topical application validated by preclinical studies showing enhanced collagen synthesis and anti-inflammatory effects
What do recent clinical trials show?
- Dhaliwal S, Rybak I, Ellis SR and others 2019. Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing. The British journal of dermatology. PMID 29947134 · doi:10.1111/bjd.16918
Bakuchiol is comparable with retinol in its ability to improve photoageing including wrinkles, pigmentation, elasticity, firmness, and overall photodamage, with significantly better tolerability and fewer side effects than retinol. - Bluemke A, Ring AP, Immeyer J and others 2022. Multidirectional activity of bakuchiol against cellular mechanisms of facial ageing - Experimental evidence for a holistic treatment approach. International journal of cosmetic science. PMID 35514037 · doi:10.1111/ics.12784
Bakuchiol demonstrated holistic anti-aging treatment through stimulation of collagen I, III and IV synthesis, MMP-1 suppression, antioxidant activity, and modulation of multiple skin aging pathways simultaneously.
2 further claims previously listed here could not be traced to a published paper and have been removed. An absence here means we could not identify the source, not that no work exists.
Recent safety updates
- Severe phototoxic reactions (blistering, erythema) reported with uncontrolled use of Psoralea corylifolia seeds, especially as home remedies for vitiligo (PubMed 2024: case report of phototoxicity in a child)
- Hepatotoxicity concerns: Psoralea corylifolia has been linked to rare cases of liver injury; several countries have issued advisories on oral supplement use. Topical bakuchiol has a significantly better safety profile than oral psoralen preparations
- Bakuchiol topical formulations show excellent tolerability with no significant irritation, peeling, or dryness compared to retinol, making it suitable for sensitive skin and pregnancy (unlike retinol)
What is it made of?
Key Active Markers
- Bergapten
- Psoralen
- Bakuchiol
- Isopsoralen
- Psoralidin
- Bavachinin
- Bakuchalcone
- Corylifolin
Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)
Dosage forms and preparation
Dosage Forms: Churna (seed powder), Taila (seed oil — topical), Capsule, Tablet, Lepa (seed paste — topical), Bakuchi Taila (for vitiligo), Ointment/cream
Standard Dosage: 500mg-2g seed powder twice daily (internal); Bakuchi oil applied topically to affected areas; 250-500mg extract capsule. CAUTION: phototoxic — photosensitivity management required.
Bioavailability: Good oral bioavailability for psoralen (~60-70% absorbed) and isopsoralen/angelicin. Psoralen reaches peak plasma levels in 1-2 hours. Bakuchiol has excellent oral bioavailability (~70%) and is also well absorbed transdermally. Psoralen undergoes hepatic metabolism via CYP enzymes and has a half-life of ~2 hours. Topical psoralen + UVA (PUVA) therapy principle: psoralen intercalates into DNA, UVA activates it — this is the basis of photochemotherapy for vitiligo and psoriasis.
Optimal Timing: Internal: after meals to reduce GI irritation. Topical: apply oil to affected area 30-60 minutes before controlled sun exposure (morning sun, 10-15 minutes). Avoid application before prolonged sun exposure.
Standardized Extract: Seed extract standardized to minimum 2% psoralen + isopsoralen. Bakuchiol-enriched extract (psoralen-free): minimum 90% bakuchiol for cosmetic applications. Seed oil with minimum 5% total furanocoumarins for PUVA therapy applications.
Shelf Life: 2 years (seed powder); 3 years (capsules/tablets); 2 years (seed oil, topical); 2 years (cream/ointment)
Storage: Seeds and seed products in airtight, light-protected containers (furanocoumarins are photoreactive). Cool and dry, below 25°C. Amber packaging mandatory for oil and topical products.
Marker Compounds: Psoralen, Isopsoralen (angelicin), Bakuchiol, Psoralidin, Corylifolin, Bavachin, Bavachinin, Isobavachalcone, Neobavaisoflavone
Extraction Methods
- Hydroalcoholic extraction (70:30) for psoralen/bakuchiol enrichment
- Cold pressing for seed oil (yield 8-12%)
- Supercritical CO2 for bakuchiol isolation
- Petroleum ether extraction for oil fraction
- Ethanol extraction for furanocoumarin enrichment
Synergistic Combinations
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Systematic reviews and meta-analyses1
- 2022. Applications of bakuchiol in dermatology: Systematic review of the literatureJournal of cosmetic dermatology. PMID 36176207 · doi:10.1111/jocd.15420
Randomised controlled trials1
- 2019. Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageingThe British journal of dermatology. PMID 29947134 · doi:10.1111/bjd.16918
Other clinical studies and reviews10
- 2025. A Review of Bavachinin and Its Derivatives as Multi-Therapeutic AgentsChemistry & biodiversity. PMID 39874061 · doi:10.1002/cbdv.202402762
- 2025. Pharmaceutical Design and Structure-activity Relationships of Psoralen and DerivativesCurrent pharmaceutical design. PMID 40108910 · doi:10.2174/0113816128365838250128060007
- 2023. Bakuchiol: A Potential Anticancer Compound from Psoralea corylifolia LinnAnti-cancer agents in medicinal chemistry. PMID 36717993 · doi:10.2174/1871520623666230130102910
- 2023. Phytochemical and Pharmacological Aspects of Psoralen - A Bioactive Furanocoumarin from Psoralea corylifolia LinnChemistry & biodiversity. PMID 37752710 · doi:10.1002/cbdv.202300867
- 2023. Bakuchiol, a natural constituent and its pharmacological benefitsF1000Research. PMID 38021404 · doi:10.12688/f1000research.129072.2
- 2019. Biological activity and health promoting effects of psoralidinDie Pharmazie. PMID 30782253 · doi:10.1691/ph.2019.8619
- 2018. Psoralea corylifolia L: Ethnobotanical, biological, and chemical aspects: A reviewPhytotherapy research : PTR. PMID 29243333 · doi:10.1002/ptr.6006
- 2016. The Chemical Constituents and Bioactivities of Psoralea corylifolia Linn.: A ReviewThe American journal of Chinese medicine. PMID 26916913 · doi:10.1142/S0192415X16500038
- 2013. Psoralea corylifolia L. (Buguchi) - folklore to modern evidence: reviewFitoterapia. PMID 23831482 · doi:10.1016/j.fitote.2013.06.016
- 2012. Isobavachalcone: an overviewChinese journal of integrative medicine. PMID 22772918 · doi:10.1007/s11655-012-1142-7
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.